8-K//Current report
Quince Therapeutics, Inc. 8-K
Accession 0001662774-25-000034
$QNCXCIK 0001662774operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:12 PM ET
Size
163.4 KB
Accession
0001662774-25-000034
Documents
- 8-Kqncx-20250604.htmPrimary
8-K
- EX-101.SCHqncx-20250604.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABqncx-20250604_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREqncx-20250604_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001662774-25-000034-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLqncx-20250604_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001662774
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:12 PM ET
- Size
- 163.4 KB